Biological E seeks nod for phase 3 trial of Corbevax as booster dose
2021-10-12
Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax. The company has sought approval as a single booster dose for those fully vaccinated with Covishield or Covaxin vaccines.The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard…Continue Reading